Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04322799
Other study ID # PolyvsHXLPE
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 7, 2013
Est. completion date June 30, 2019

Study information

Verified date March 2020
Source Umeå University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A prospective randomized study comparing two types of cemented acetabular components, a highly-crosslinked polyethylene or conventional polyethylene in total hip arthroplasty. Primary outcome are component wear measured by RSA, secondary outcomes are migration and complications. Patients are evaluated 5 years postoperatively.


Description:

Background:

Total hip replacements is a cost effective treatment of a symptomatic degenerative hip disease. Cemented total hip replacements are the most common implants in Sweden (Swedish hip registry, 2009).

Wear of ultra high molecular weight polyethylene has been a issue with regard to implant survival. At the time of the shift of the millennium highly cross-linked polyethylene was introduced to the markets. Experimental studies had shown reduction of wear in hip simulator studies (McKellop,1999). Subsequently the intention is to reduce osteolysis and implant loosening. Single surgeon pilot studies in the 1970 (Wroblevski et al. 1996, Oonishi 1998, Grobelaar 1999) were the first clinical series with good results leading to the development of 2nd generation highly cross-linked polyethylenes which is now the almost exclusively used PE worldwide. So far medium term clinical evaluation and laboratory assessment have showed reduced wear and good mechanical properties (Digas et al. 2003, 2004, 2007, Röhrl et al. 2005, 2007, D´Antonio et al. 2005)

Production of highly crosslinked polyethylene (HXLPE) consists of several steps. First the PE material is crosslinked by being subjected to either gamma irradiation of various intensity or electron beam irradiation. The second step is to remove the free radicals created during the irradiation. This is done either by annealing (i.e. warming up the PE to just under its melting temperature) or melting (i.e. warming up the PE to above its melting temperature). Finally, the implant is sterilized either by gamma irradiation or Ethylene Oxide and packed in vacuum or inert atmosphere.There are some possible drawbacks and challenges in the process of cross-linking polyethylene with regard to preserving the mechanical properties and elimination of free radicals (Kurtz et al. 2006, Currier et al. 2007).

Submelt annealing preserves mechanical properties but on the other hand cannot eliminate all free radicals existing in the PE. Retrieval-studies of some 2nd generation highly cross-linked polyethylenes manufactured in this way have shown signs of oxidation. The in-vivo oxidation has been located in the non articulating area such as the circumference of the acetabular liner. It has been discussed that the femoral head may protect the polyethylene against oxidation, and hence prevent the possible negative consequences of remaining free radicals (Currier et al 2007).

Melting the polyethylene eliminates all free radicals but alters the mechanical properties. This has led to PE cracks and implant failure in some clinical studies (Furmanski et al. 2009), whereas it has not been seen in other.

Finally, wear particles of highly crosslinked polyethylene are more often in the submicron size compared to conventional PE. Although these particles have a higher biological activity (Fisher et al. 2006), results of recent studies show however, that the overall risk for osteolysis and aggressiveness of highly cross-linked particles is reduced (Galvin et al. 2007).

Because of differences in the manufacturing processes of highly crosslinking PE between manufacturers (i.e. different GUR used, type of irradiation, intensity of irradiation, postirradiative treatment, type of sterilization and packing, etc, etc) all highly crosslinked polyethylenes differ somewhat from each other. One can not extrapolate results of in vitro or in vivo wear studies of one manufacturer to another. Also, because of these manufacturing differences, fixation characteristics may differ between the various types of HXLPEs. Therefore it is imperative that all new highly crosslinked polyethylenes are subjected to clinical studies of their wear and fixation performance using high accuracy methods before being used extensively.

Methods:

A prospective randomized study comparing acetabular components made of HXLPE or conventional PE in total hip arthroplasty. The study will be conducted at Department of Orthopaedics, Umeå University, Umeå, Sweden.

Aim of study The aim of the study is to compare the wear and migration of a 2nd generation polyethylene from Link with conventional polyethylene in an all-poly cemented acetabular cup of the Lubinus brand using radiostereometric analysis (RSA) with 5-year follow-up.

Hypothesis The H0-hypothesis is that the difference with in wear between HXLPE and conventional PE will not increase up to 5-year follow-up.

Material Patients (age 50 years and above) with primary osteoarthritis between 2013 and 2014 at the orthopaedic department at the county hospital (Lycksele) affiliated to Umeå University hospital, Sweden. Patients were treated with a cemented total hip arthroplasty. At surgery, after the acetabulum was reamed, randomization was performed by opening of a consecutively numbered sealed envelope informing whether a cup made of HXLPE or conventional PE should be inserted. The envelopes were kept far away from the operation theatre and were opened by a research nurse contacted by telephone. Randomization was stratified for gender. Within each stratum there was block randomization with 6 permutations in each block.

Patients have been followed for 5 years postoperatively.

Implants • Acetabular cup Intervention: Link-Ticona GUR 1020 HXLPE, 32 mm inner diameter (Trade name Lubinus® X-LINKed® )

Control: Link-Chirulene GUR 1020 UHMWPE, 32 mm inner diameter (Trade name Lubinus ® UHMWPE)

• Femur stem Test and control: Lubinus® SP II®, CrCo femoral head, 32 mm diameter

Radio Sterometric Analysis (RSA) Radiostereometric analysis measurements will be performed 5 years postoperatively.

Wear will be measured as penetration of the femoral head into the polyethylene in the proximal, proximo-medial (2D pm), proximo-posterior (2D pp), and proximo-medial-posterior (3D) directions. Since the penetration during the initial 3 months represents polyethylene yield or bedding in, wear measurements will be reported from 3 months and up to 5 years postoperatively.

Quality of cup fixation will be measured as rotations of the cup around the three cardinal axes in relation to acetabulum with the postoperative examination as reference.

The RSA measurements will be analysed at Umeå University Hospital. Patient data will be saved in a specific research database at Umeå University Hospital following specific guidelines from the national data security committee.

Ethical approval The study has been approved by the Ethics Committee of Umeå University (Dnr 2011-173-31M, 2018-34-31M).

Sample size With a mean difference in wear at 2 years of 0.1 mm or more (SD ± 0.1) between the groups (p< 0.05), 25 patients in each group will give a power of > 80%. In order to cater for losses during the follow up a total of 57 patients will be enrolled.

Scientific Value All new materials should be monitored closely and introduced in small study groups using a high precision measurement technique. Many markets require such tests before acceptance for general use is given. The new highly crosslinked polyethylene from Link-Ticona is not equivalent to current highly crosslinked polyethylenes on the market, and one can not extrapolate wear results from these other designs.


Recruitment information / eligibility

Status Completed
Enrollment 57
Est. completion date June 30, 2019
Est. primary completion date December 4, 2014
Accepts healthy volunteers No
Gender All
Age group 50 Years and older
Eligibility Inclusion Criteria:

- Primary osteoarthritis

- Age 50 years and above

- Patients who understand the conditions of the study and are willing to participate for the length of the prescribed follow-up

Exclusion Criteria:

- Rheumatoid Arthritis

- Grossly abnormal hip anatomy (severe dysplasia)

- Fracture sequelae

- Patients who, as judged by the surgeon, are mentally incompetent or are reasonable unlikely to be compliant with the requirements of the study

- Immune suppression or grave systemic illness

Study Design


Intervention

Procedure:
Device: Randomization between prosthetic components
Patients are randomized between two types of cup components in total hip arthroplasty. Identical cups made of either highly-crosslinked polyethylene or conventional polyethylene.

Locations

Country Name City State
Sweden Lycksele hospital Lycksele

Sponsors (1)

Lead Sponsor Collaborator
Umeå University

Country where clinical trial is conducted

Sweden, 

References & Publications (9)

Bragdon CR, Greene ME, Freiberg AA, Harris WH, Malchau H. Radiostereometric analysis comparison of wear of highly cross-linked polyethylene against 36- vs 28-mm femoral heads. J Arthroplasty. 2007 Sep;22(6 Suppl 2):125-9. Epub 2007 Jul 26. — View Citation

D'Antonio JA, Manley MT, Capello WN, Bierbaum BE, Ramakrishnan R, Naughton M, Sutton K. Five-year experience with Crossfire highly cross-linked polyethylene. Clin Orthop Relat Res. 2005 Dec;441:143-50. — View Citation

Digas G, Kärrholm J, Thanner J, Herberts P. 5-year experience of highly cross-linked polyethylene in cemented and uncemented sockets: two randomized studies using radiostereometric analysis. Acta Orthop. 2007 Dec;78(6):746-54. doi: 10.1080/17453670710014518. — View Citation

Kurtz SM, Hozack WJ, Purtill JJ, Marcolongo M, Kraay MJ, Goldberg VM, Sharkey PF, Parvizi J, Rimnac CM, Edidin AA. 2006 Otto Aufranc Award Paper: significance of in vivo degradation for polyethylene in total hip arthroplasty. Clin Orthop Relat Res. 2006 Dec;453:47-57. — View Citation

Lerf R, Zurbrügg D, Delfosse D. Use of vitamin E to protect cross-linked UHMWPE from oxidation. Biomaterials. 2010 May;31(13):3643-8. doi: 10.1016/j.biomaterials.2010.01.076. Epub 2010 Feb 9. — View Citation

McKellop H, Shen FW, Lu B, Campbell P, Salovey R. Development of an extremely wear-resistant ultra high molecular weight polyethylene for total hip replacements. J Orthop Res. 1999 Mar;17(2):157-67. — View Citation

Rajadhyaksha AD, Brotea C, Cheung Y, Kuhn C, Ramakrishnan R, Zelicof SB. Five-year comparative study of highly cross-linked (crossfire) and traditional polyethylene. J Arthroplasty. 2009 Feb;24(2):161-7. doi: 10.1016/j.arth.2007.09.015. Epub 2008 Mar 4. — View Citation

Röhrl SM, Li MG, Nilsson KG, Nivbrant B. Very low wear of non-remelted highly cross-linked polyethylene cups: an RSA study lasting up to 6 years. Acta Orthop. 2007 Dec;78(6):739-45. doi: 10.1080/17453670710014509. — View Citation

Sköldenberg OG, Rysinska AD, Chammout G, Salemyr M, Mukka SS, Bodén H, Eisler T. A randomized double-blind noninferiority trial, evaluating migration of a cemented vitamin E-stabilized highly crosslinked component compared with a standard polyethylene component in reverse hybrid total hip arthroplasty. Bone Joint J. 2019 Oct;101-B(10):1192-1198. doi: 10.1302/0301-620X.101B10.BJJ-2019-0456.R2. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Magnitude of Polyethylene Wear The size of the femoral component penetration into the polyethylene measured in millimeters per year and the volumetric annual wear millimetres with radiostereometric (RSA) analysis of radiographs. 0-5 years
Secondary Magnitude of Cup Migration Migration measured in millimetres per year with radiostereometric (RSA) analysis of radiographs. Radiostereometric analysis (RSA) is a stereo X-ray technique used in clinical research studies to evaluate micro-motion and wear of orthopaedic implants within bone. The method has a high accuracy and precision. Technical requirements include the need for implanted marker beads and radiograph view angles determined by a calibration cage. 0-5 years
Secondary Surgical complications Surgical complications and reapportions during the study period. 0-5 years
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05773261 - Clinical Investigation Comparing Two Different Ultra-porous Coated Surfaces of Uncemented Cups N/A
Recruiting NCT05223777 - KINCISE™ Surgical Automated System in Total Hip Arthroplasty (THA) N/A
Recruiting NCT04731077 - Avenir Complete Post-Market Clinical Follow-Up Study N/A
Not yet recruiting NCT04448106 - Autologous Adipose Tissue-Derived Mesenchymal Stem Cells (AdMSCs) for Osteoarthritis Phase 2
Completed NCT05070871 - A Clinical Trial Investigating the Effect of Salmon Bone Meal on Osteoarthritis Among Men and Women N/A
Not yet recruiting NCT06162195 - The ACTIVE Trial: A Prospective Randomised Control Trial Of The H1 Implant Versus Total Hip Replacement N/A
Withdrawn NCT02743208 - Evaluation of a Short Femoral Stem in Total Hip Arthroplasty N/A
Completed NCT02944448 - A Study Evaluating Pain Relief and Safety of Orally Administered CR845 in Patients With Osteoarthritis of Hip or Knee Phase 2
Active, not recruiting NCT02229279 - Evaluation of Teleconsulting on Rehabilitation After Hip and Knee Surgical Procedures N/A
Active, not recruiting NCT02851992 - A Prospective Study to Evaluate Long-term Clinical Outcomes of the GTS Cementless Femoral Stem N/A
Completed NCT01700933 - Dose-response: Exercise Therapy on Hip Osteoarthritis N/A
Completed NCT01618708 - A Study of the Safety and Effectiveness of Synvisc-One® (Hylan G-F 20) in Patients With Primary Osteoarthritis of the Hip N/A
Completed NCT01214954 - Early Rehabilitation After Total Hip Replacement N/A
Active, not recruiting NCT00294424 - Study on Costs and Effects of Waiting Time in Total Hip and Knee Replacements N/A
Terminated NCT00588861 - Total Hip Replacement With the Answer® Hip Stem and Ranawat/Burnstein® Shell Using Simplex® or Palacos® Bone Cement N/A
Withdrawn NCT05054595 - Audio-Recorded vs. Nurse-Led Brief Mindfulness-Based Intervention N/A
Terminated NCT00973141 - A Dose-ranging Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Osteoarthritis-related Pain Phase 2
Recruiting NCT05014113 - H-28 DELTA ST-C and Minima Retrospective Study.
Completed NCT01066936 - Mini Stem DEXA (Dual Energy X-ray Absorptiometry)
Recruiting NCT05530551 - Effect of Single vs Multiple Prophylactic Antibiotic Doses on PJI Following Primary THA in Patients With OA N/A